VolitionRX Ltd. (VNRX)
0.1621
0.00 (0.00%)
USD |
NYAM |
Nov 20, 16:00
0.1629
0.00 (0.00%)
After-Hours: 20:00
VolitionRX Enterprise Value : 9.717M for Nov. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 9.717M |
| November 19, 2026 | 9.802M |
| November 18, 2026 | 10.40M |
| November 17, 2026 | 10.59M |
| November 16, 2026 | 10.95M |
| November 13, 2026 | 11.95M |
| November 12, 2026 | 10.45M |
| November 11, 2026 | 11.08M |
| November 10, 2026 | 10.45M |
| November 09, 2026 | 10.96M |
| November 06, 2026 | 10.83M |
| November 05, 2026 | 10.60M |
| November 04, 2026 | 11.06M |
| November 03, 2026 | 10.73M |
| November 02, 2026 | 11.29M |
| October 30, 2026 | 10.81M |
| October 29, 2026 | 10.88M |
| October 28, 2026 | 10.36M |
| October 27, 2026 | 10.47M |
| October 26, 2026 | 10.26M |
| October 23, 2026 | 10.11M |
| October 22, 2026 | 9.947M |
| October 21, 2026 | 9.858M |
| October 20, 2026 | 10.08M |
| October 19, 2026 | 10.10M |
| Date | Value |
|---|---|
| October 16, 2026 | 10.31M |
| October 15, 2026 | 10.58M |
| October 14, 2026 | 10.27M |
| October 13, 2026 | 10.46M |
| October 12, 2026 | 11.06M |
| October 09, 2026 | 11.33M |
| October 08, 2026 | 11.60M |
| October 07, 2026 | 11.81M |
| October 06, 2026 | 12.37M |
| October 05, 2026 | 12.01M |
| October 02, 2026 | 12.11M |
| October 01, 2026 | 12.10M |
| September 30, 2026 | 12.86M |
| September 29, 2026 | 10.33M |
| September 28, 2026 | 10.29M |
| September 25, 2026 | 10.36M |
| September 24, 2026 | 10.21M |
| September 23, 2026 | 10.22M |
| September 22, 2026 | 10.42M |
| September 21, 2026 | 10.44M |
| September 18, 2026 | 10.38M |
| September 17, 2026 | 10.68M |
| September 16, 2026 | 10.56M |
| September 15, 2026 | 10.73M |
| September 14, 2026 | 11.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| PAVmed, Inc. | 1.885M |
| Owlet, Inc. | 80.60M |
| Abbott Laboratories | 205.85B |
| Align Technology, Inc. | 9.970B |
| AngioDynamics, Inc. | 435.37M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.911M |
| Revenue (Quarterly) | 1.614M |
| Total Expenses (Quarterly) | 5.517M |
| EPS Diluted (Quarterly) | -0.2065 |
| Gross Profit Margin (Quarterly) | 83.80% |
| Profit Margin (Quarterly) | -242.3% |
| Earnings Yield | -1.88K% |
| Normalized Earnings Yield | -1696.92 |